Eli Lilly has partnered with Chinese digital healthcare platform JD Health International to sell its GLP-1s to patients online, Bloomberg reported Aug. 29.
The collaboration will offer a streamlined, one-stop service through JD Health, including online consultations, prescriptions, drug delivery and follow-up care, according to a statement posted on Eli Lilly’s WeChat account. The drugmaker currently markets Mounjaro for both obesity and diabetes in China.
China’s state medical insurance previously said it wouldn’t cover drugs for weight loss purposes, prompting more drugmakers to prioritize online drug channels.
Eli Lilly’s rival Novo Nordisk has also partnered with major platforms, including JD Health, Tencent Health, Ping An Healthcare and Alibaba Health.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
